Matches in SemOpenAlex for { <https://semopenalex.org/work/W2359317503> ?p ?o ?g. }
- W2359317503 endingPage "571" @default.
- W2359317503 startingPage "563" @default.
- W2359317503 abstract "Background Testosterone replacement therapy (TRT) prescriptions have increased several-fold in the last decade. There have been concerns regarding a possible increased incidence of DVT and pulmonary embolism (PE) with TRT. Few data support the association between TRT and DVT/PE. We evaluated the incidence of DVT and PE in men who were prescribed TRT for low serum total testosterone (sTT) levels. Methods This is a retrospective cohort study, conducted using data obtained from the Veterans Affairs Informatics and Computing Infrastructure. We compared the incidence of DVT/PE between those who received TRT and subsequently had normal on-treatment sTT levels (Gp1), those who received TRT but continued to have low on-treatment sTT (Gp2), and those who did not receive TRT (Gp3). Those with prior history of DVT/PE, cancer, hypercoagulable state, and chronic anticoagulation were excluded. Results The final cohort consisted of 71,407 subjects with low baseline sTT. Of these, 10,854 did not receive TRT (Gp3) and 60,553 received TRT. Of those who received TRT, 38,362 achieved normal sTT (Gp1) while 22,191 continued to have low sTT (Gp2). The incidence of DVT/PE was 0.5%, 0.4%, and 0.4% in Gp1, Gp2, and Gp3, respectively. Univariate, multivariate, and stabilized inverse probability of treatment weights analyses showed no statistically significant difference in DVT/PE-free survival between the various groups. Conclusions This study did not detect a significant association between testosterone replacement therapy and risk of DVT/PE in adult men with low sTT who were at low to moderate baseline risk of DVT/PE. Testosterone replacement therapy (TRT) prescriptions have increased several-fold in the last decade. There have been concerns regarding a possible increased incidence of DVT and pulmonary embolism (PE) with TRT. Few data support the association between TRT and DVT/PE. We evaluated the incidence of DVT and PE in men who were prescribed TRT for low serum total testosterone (sTT) levels. This is a retrospective cohort study, conducted using data obtained from the Veterans Affairs Informatics and Computing Infrastructure. We compared the incidence of DVT/PE between those who received TRT and subsequently had normal on-treatment sTT levels (Gp1), those who received TRT but continued to have low on-treatment sTT (Gp2), and those who did not receive TRT (Gp3). Those with prior history of DVT/PE, cancer, hypercoagulable state, and chronic anticoagulation were excluded. The final cohort consisted of 71,407 subjects with low baseline sTT. Of these, 10,854 did not receive TRT (Gp3) and 60,553 received TRT. Of those who received TRT, 38,362 achieved normal sTT (Gp1) while 22,191 continued to have low sTT (Gp2). The incidence of DVT/PE was 0.5%, 0.4%, and 0.4% in Gp1, Gp2, and Gp3, respectively. Univariate, multivariate, and stabilized inverse probability of treatment weights analyses showed no statistically significant difference in DVT/PE-free survival between the various groups. This study did not detect a significant association between testosterone replacement therapy and risk of DVT/PE in adult men with low sTT who were at low to moderate baseline risk of DVT/PE." @default.
- W2359317503 created "2016-06-24" @default.
- W2359317503 creator A5016700682 @default.
- W2359317503 creator A5020678118 @default.
- W2359317503 creator A5026588307 @default.
- W2359317503 creator A5029636462 @default.
- W2359317503 creator A5039759417 @default.
- W2359317503 creator A5055145699 @default.
- W2359317503 creator A5057018598 @default.
- W2359317503 creator A5067513796 @default.
- W2359317503 creator A5070606332 @default.
- W2359317503 creator A5078398693 @default.
- W2359317503 date "2016-09-01" @default.
- W2359317503 modified "2023-10-10" @default.
- W2359317503 title "Association Between Testosterone Replacement Therapy and the Incidence of DVT and Pulmonary Embolism" @default.
- W2359317503 cites W1593442063 @default.
- W2359317503 cites W1818039308 @default.
- W2359317503 cites W1959554618 @default.
- W2359317503 cites W1969828880 @default.
- W2359317503 cites W1975148982 @default.
- W2359317503 cites W1979524712 @default.
- W2359317503 cites W1984631757 @default.
- W2359317503 cites W2009187570 @default.
- W2359317503 cites W2012043101 @default.
- W2359317503 cites W2017658545 @default.
- W2359317503 cites W2027586930 @default.
- W2359317503 cites W2030952860 @default.
- W2359317503 cites W2033358479 @default.
- W2359317503 cites W2036193982 @default.
- W2359317503 cites W2036769856 @default.
- W2359317503 cites W2045492405 @default.
- W2359317503 cites W2048565444 @default.
- W2359317503 cites W2076402620 @default.
- W2359317503 cites W2079838674 @default.
- W2359317503 cites W2082598020 @default.
- W2359317503 cites W2083421211 @default.
- W2359317503 cites W2099814945 @default.
- W2359317503 cites W2102205904 @default.
- W2359317503 cites W2106372654 @default.
- W2359317503 cites W2110318301 @default.
- W2359317503 cites W2112188806 @default.
- W2359317503 cites W2113264115 @default.
- W2359317503 cites W2123347684 @default.
- W2359317503 cites W2125007558 @default.
- W2359317503 cites W2127301944 @default.
- W2359317503 cites W2132123717 @default.
- W2359317503 cites W2142563833 @default.
- W2359317503 cites W2142839710 @default.
- W2359317503 cites W2144756371 @default.
- W2359317503 cites W2155877918 @default.
- W2359317503 cites W2167358383 @default.
- W2359317503 cites W2413076885 @default.
- W2359317503 doi "https://doi.org/10.1016/j.chest.2016.05.007" @default.
- W2359317503 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27179907" @default.
- W2359317503 hasPublicationYear "2016" @default.
- W2359317503 type Work @default.
- W2359317503 sameAs 2359317503 @default.
- W2359317503 citedByCount "53" @default.
- W2359317503 countsByYear W23593175032016 @default.
- W2359317503 countsByYear W23593175032017 @default.
- W2359317503 countsByYear W23593175032018 @default.
- W2359317503 countsByYear W23593175032019 @default.
- W2359317503 countsByYear W23593175032020 @default.
- W2359317503 countsByYear W23593175032021 @default.
- W2359317503 countsByYear W23593175032022 @default.
- W2359317503 countsByYear W23593175032023 @default.
- W2359317503 crossrefType "journal-article" @default.
- W2359317503 hasAuthorship W2359317503A5016700682 @default.
- W2359317503 hasAuthorship W2359317503A5020678118 @default.
- W2359317503 hasAuthorship W2359317503A5026588307 @default.
- W2359317503 hasAuthorship W2359317503A5029636462 @default.
- W2359317503 hasAuthorship W2359317503A5039759417 @default.
- W2359317503 hasAuthorship W2359317503A5055145699 @default.
- W2359317503 hasAuthorship W2359317503A5057018598 @default.
- W2359317503 hasAuthorship W2359317503A5067513796 @default.
- W2359317503 hasAuthorship W2359317503A5070606332 @default.
- W2359317503 hasAuthorship W2359317503A5078398693 @default.
- W2359317503 hasConcept C120665830 @default.
- W2359317503 hasConcept C121332964 @default.
- W2359317503 hasConcept C121608353 @default.
- W2359317503 hasConcept C126322002 @default.
- W2359317503 hasConcept C141071460 @default.
- W2359317503 hasConcept C167135981 @default.
- W2359317503 hasConcept C201903717 @default.
- W2359317503 hasConcept C2775969662 @default.
- W2359317503 hasConcept C2776265017 @default.
- W2359317503 hasConcept C2779279991 @default.
- W2359317503 hasConcept C2780192828 @default.
- W2359317503 hasConcept C61511704 @default.
- W2359317503 hasConcept C71924100 @default.
- W2359317503 hasConcept C72563966 @default.
- W2359317503 hasConceptScore W2359317503C120665830 @default.
- W2359317503 hasConceptScore W2359317503C121332964 @default.
- W2359317503 hasConceptScore W2359317503C121608353 @default.
- W2359317503 hasConceptScore W2359317503C126322002 @default.
- W2359317503 hasConceptScore W2359317503C141071460 @default.
- W2359317503 hasConceptScore W2359317503C167135981 @default.
- W2359317503 hasConceptScore W2359317503C201903717 @default.